Skip to content

Pharminent

Primary Menu
  • Home
    • Pro Hub
Light/Dark Button
Hub
  • Home
  • Clinical Data
  • Kainova expands DT 7012 trial into Europe
  • Clinical Data

Kainova expands DT 7012 trial into Europe

PharmaTimes

First patient dosed as DOMISOL study grows beyond Australia

Clinical DataOncologyRead full story

pharminent April 9, 2026 (Last updated: April 9, 2026)

PharmaTimes

First patient dosed as DOMISOL study grows beyond Australia

Clinical DataOncologyRead full story

Post navigation

Previous: Roche sticks with C4T, adding up to $1B for molecular glue partnership
Next: Innovent’s CDMO gets green light to make biologics at large Chinese plant

Related Stories

  • Clinical Data

Novartis hit as Lp(a) drug fails cardio outcomes trial

pharminent September 7, 2026
  • Clinical Data

Major trial of Roche Alzheimer’s drug kicks off in Europe

pharminent September 7, 2026
  • Clinical Data

AbbVie’s T cell engager delivers survival benefit in Phase 3 multiple myeloma study

pharminent September 4, 2026
  • Home
  • Contact
© 2026 All rights reserved. | ReviewNews by AF themes.